Alagpulinsa, D. A., Ayyadevara, S., Yaccoby, S., & Shmookler Reis, R. J. (2015). A cyclin-dependent kinase inhibitor, dinaciclib, impairs homologous recombination and sensitizes multiple myeloma cells to PARP inhibition. Mol Cancer Ther.
Chicago Stili AlıntıAlagpulinsa, David A., Srinivas Ayyadevara, Shmuel Yaccoby, ve Robert J. Shmookler Reis. "A Cyclin-dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition." Mol Cancer Ther 2015.
MLA AlıntıAlagpulinsa, David A., Srinivas Ayyadevara, Shmuel Yaccoby, ve Robert J. Shmookler Reis. "A Cyclin-dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition." Mol Cancer Ther 2015.